Sergey Menis

7.5k total citations · 1 hit paper
22 papers, 2.6k citations indexed

About

Sergey Menis is a scholar working on Virology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sergey Menis has authored 22 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Virology, 15 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sergey Menis's work include HIV Research and Treatment (20 papers), Immune Cell Function and Interaction (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Sergey Menis is often cited by papers focused on HIV Research and Treatment (20 papers), Immune Cell Function and Interaction (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Sergey Menis collaborates with scholars based in United States, United Kingdom and Netherlands. Sergey Menis's co-authors include William R. Schief, Daniel W. Kulp, Devin Sok, Dennis R. Burton, Joseph G. Jardine, Oleksandr Kalyuzhniy, David Nemazee, Takayuki Ota, Darrell J. Irvine and Meaghan Jones and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Sergey Menis

22 papers receiving 2.6k citations

Hit Papers

Rational HIV Immunogen Design to Target Specific Germline... 2013 2026 2017 2021 2013 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergey Menis United States 18 1.4k 1.3k 1.2k 632 588 22 2.6k
Catarina E. Hioe United States 27 1.1k 0.8× 1.1k 0.8× 532 0.4× 280 0.4× 479 0.8× 82 1.9k
Celia C. LaBranche United States 33 2.8k 2.0× 1.8k 1.3× 1.2k 1.0× 629 1.0× 1.3k 2.2× 149 3.9k
Gilad Ofek United States 15 1.8k 1.3× 990 0.7× 952 0.8× 821 1.3× 591 1.0× 20 2.4k
Jeffrey D. Ahlers United States 29 1.3k 1.0× 2.4k 1.8× 904 0.8× 145 0.2× 529 0.9× 44 3.4k
Thomas J. Ketas United States 33 2.9k 2.1× 1.4k 1.0× 1.3k 1.1× 731 1.2× 1.7k 2.8× 45 4.0k
Lynda Tussey United States 23 308 0.2× 1.7k 1.2× 773 0.6× 243 0.4× 458 0.8× 35 2.7k
Shiu-Lok Hu United States 29 2.1k 1.5× 1.5k 1.1× 896 0.7× 196 0.3× 889 1.5× 71 3.2k
Priyanthi N.P. Gnanapragasam United States 19 1.2k 0.9× 933 0.7× 771 0.6× 749 1.2× 684 1.2× 28 2.1k
Vaniambadi S. Kalyanaraman United States 29 1.7k 1.2× 1.3k 1.0× 456 0.4× 200 0.3× 573 1.0× 66 2.3k
Rinaldo Zurbriggen Switzerland 28 279 0.2× 874 0.7× 788 0.7× 203 0.3× 422 0.7× 58 2.0k

Countries citing papers authored by Sergey Menis

Since Specialization
Citations

This map shows the geographic impact of Sergey Menis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Menis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Menis more than expected).

Fields of papers citing papers by Sergey Menis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey Menis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Menis. The network helps show where Sergey Menis may publish in the future.

Co-authorship network of co-authors of Sergey Menis

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey Menis. A scholar is included among the top collaborators of Sergey Menis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey Menis. Sergey Menis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Vaneet K., Sergey Menis, Evan T. Brower, et al.. (2024). Use of Transient Transfection for cGMP Manufacturing of eOD-GT8 60mer, a Self-Assembling Nanoparticle Germline-Targeting HIV-1 Vaccine Candidate. Pharmaceutics. 16(6). 742–742. 2 indexed citations
2.
Martin, Jacob T., Brittany L. Hartwell, Mariane B. Melo, et al.. (2021). Combined PET and whole-tissue imaging of lymphatic-targeting vaccines in non-human primates. Biomaterials. 275. 120868–120868. 24 indexed citations
3.
Kato, Yu, Robert Abbott, Sonya Haupt, et al.. (2020). Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo. Immunity. 53(3). 548–563.e8. 135 indexed citations
4.
Melo, Mariane B., Ely Porter, Yuan Zhang, et al.. (2019). Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles. Molecular Therapy. 27(12). 2080–2090. 65 indexed citations
5.
Crooks, Ema T., Samantha L. Grimley, Michelle D. Cully, et al.. (2018). Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation. PLoS Pathogens. 14(5). e1007024–e1007024. 19 indexed citations
6.
Tokatlian, Talar, Benjamin J. Read, Christopher A. Jones, et al.. (2018). Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers. Science. 363(6427). 649–654. 212 indexed citations
7.
Cao, Liwei, Matthias Pauthner, Raiees Andrabi, et al.. (2018). Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer. Nature Communications. 9(1). 3693–3693. 86 indexed citations
8.
Tokatlian, Talar, Daniel W. Kulp, Christopher A. Jones, et al.. (2018). Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes. Scientific Reports. 8(1). 16527–16527. 62 indexed citations
9.
Crooks, Ema T., Keiko Osawa, Tommy R. Tong, et al.. (2017). Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction. Virology. 505. 193–209. 24 indexed citations
10.
Abbott, Robert, Jeong Hyun Lee, Sergey Menis, et al.. (2017). Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens. Immunity. 48(1). 133–146.e6. 204 indexed citations
11.
Cao, Liwei, Jolene K. Diedrich, Daniel W. Kulp, et al.. (2017). Global site-specific N-glycosylation analysis of HIV envelope glycoprotein. Nature Communications. 8(1). 14954–14954. 141 indexed citations
12.
Sok, Devin, Bryan Briney, Joseph G. Jardine, et al.. (2016). Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice. Science. 353(6307). 1557–1560. 109 indexed citations
13.
McCoy, Laura E., Marit J. van Gils, Gabriel Ozorowski, et al.. (2016). Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies. Cell Reports. 16(9). 2327–2338. 140 indexed citations
14.
Pritchard, Laura K., Daniel I. R. Spencer, Louise Royle, et al.. (2015). Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies. Nature Communications. 6(1). 7479–7479. 96 indexed citations
15.
Jardine, Joseph G., Takayuki Ota, Devin Sok, et al.. (2015). Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen. Science. 349(6244). 156–161. 260 indexed citations
16.
Sok, Devin, Katie J. Doores, Bryan Briney, et al.. (2014). Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV. Science Translational Medicine. 6(236). 236ra63–236ra63. 139 indexed citations
17.
Isik, Gözde, Nancy P. Y. Chung, Thijs van Montfort, et al.. (2013). An HIV-1 Envelope Glycoprotein Trimer with an Embedded IL-21 Domain Activates Human B Cells. PLoS ONE. 8(6). e67309–e67309. 4 indexed citations
18.
Jardine, Joseph G., Jean‐Philippe Julien, Sergey Menis, et al.. (2013). Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors. Science. 340(6133). 711–716. 529 indexed citations breakdown →
19.
Jardine, Joseph G., Oleksandr Kalyuzhniy, Toshiyuki Ota, et al.. (2012). Rational immunogen design to target specific germline B cell receptors. Retrovirology. 9(S2). 3 indexed citations
20.
Montfort, Thijs van, Mark Melchers, Gözde Isik, et al.. (2011). A Chimeric HIV-1 Envelope Glycoprotein Trimer with an Embedded Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Domain Induces Enhanced Antibody and T Cell Responses. Journal of Biological Chemistry. 286(25). 22250–22261. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026